Virtual colonoscopy tops conventional screening

Article

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

Dr. Perry Pickhardt, an associate professor of radiology at the University of Wisconsin, and Dr. Cesare Hassan, a gastroenterologist in Rome, collaborated on the analysis. Their findings contradict previous ones showing that colonoscopy and flexible sigmoidoscopy of all sizes of polyps are more cost-effective than CT colonography. Earlier studies, however, ignored CT colonography guidelines on reporting only polyps greater than 5 mm. The cost per life-year gained from CT screening with a 6-mm threshold for follow-up was $4361 compared with $9180 for colonoscopy. The cost per life-year gained with CT screening with no polyp size threshold was $7138, compared with $7407 for flexible sigmoidoscopy.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.